Histones and their practical application in bone tumors: Do I always need them?

Area of Science:

• Oncology
• Pathology
• Genetics

Background:

• Giant cell-rich bone neoplasms pose diagnostic challenges due to overlapping features.
• Limited biopsy material further complicates accurate diagnosis.

Purpose of the Study:

• To review the evolution and application of genetic testing in diagnosing bone neoplasms.
• To provide a practical guide for utilizing histone mutation analysis in bone tumor pathology.

Main Methods:

• Review of diagnostic criteria for giant cell-rich bone neoplasms.
• Analysis of the discovery and utility of driver histone mutations in giant cell tumor of bone (GCTB) and chondroblastoma.
• Evaluation of USP6 rearrangements in aneurysmal bone cyst diagnosis.

Main Results:

• Histone mutations provide objective ancillary tools for differentiating giant cell-rich neoplasms.
• Recognition of histone mutations has refined understanding of entities like "malignant chondroblastoma" and "aneurysmal bone cyst-like change."

Conclusions:

• Genetic markers, particularly histone mutations, have significantly improved the diagnostic accuracy of bone tumors.
• These advancements aid pathologists in distinguishing histologically similar giant cell-rich neoplasms.